Shenzhen Salubris Pharmaceuticals Co., Ltd.

SZSE:002294.SZ

29.64 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income 580.066634.218528.32250.135681.8411,454.5811,436.881,390.0391,269.6741,043.384833.26635.552405.448355.51215.679116.94273.13834.239
Depreciation & Amortization 345.606320.158304.268246.025229.362167.361125.974112.73275.67363.34253.84741.49731.73419.90713.2528.0536.6814.81
Deferred Income Tax 020.921-3.571-37.135-7.766-1.121-6.1278.87813.001000000000
Stock Based Compensation 000000000000000000
Change In Working Capital -177.116-140.914297.411740.024367.617-272.88-82.134-81.874-293.558-111.106-230.232-169.772-183.087-197.009-101.606-49.784-27.89-28.073
Accounts Receivables 3.962-89.41669.975613.445356.351-61.116.885-32.996-158.453-165.507-323.611-189.13000000
Inventory 51.233-114.11-46.531111.42467.55-86.932-154.40417.102-188.74310.22765.257-56.67255.541-74.917-51.295-25.09-28.984-5.749
Accounts Payables -219.18541.691277.53952.29-48.518-123.72661.512-74.85840.637000000000
Other Working Capital -13.12620.921-3.571-37.135-7.766-185.94872.27-98.975-104.815-121.333-295.489-113.1-238.627-122.092-50.311-24.6941.094-22.324
Other Non Cash Items 121.236135.68154.977338.145227.825-8.399-22.99813.9154.24-13.37111.64613.93718.2238.2426.9572.6820.8251.029
Operating Cash Flow 869.792970.8051,184.9791,374.3291,506.6451,340.6641,457.7221,434.8121,056.029982.249668.522521.214272.319186.649134.28277.89352.75412.005
Investing Activities:
Investments In Property Plant And Equipment -670.999-598.96-482.501-642.465-457.186-332.87-331.668-245.057-235.569-200.654-427.203-286.749-252.6-223.478-135.677-61.479-13.705-9.705
Acquisitions Net 0-82.8421.593643.359457.331-213.896332.004245.813-414.238-202.71900252.646223.478061.47909.705
Purchases Of Investments -2,140.98-1,371.093-498.079-858.293-2,389.072-2,795.926-3,197.906-312.841-752.5-746-200-1.5-170-500-350-10
Sales Maturities Of Investments 1,410.225696.159609.339650.4242,633.8062,408.9382,325.91327.138956.421716.53100171.00750.374035.0661.98.1
Other Investing Activites 0.61583.4280-642.465-457.1860.73-331.668-245.0570.0080.0240.0110.017-252.6-223.4783-61.479-13.705-9.705
Investing Cash Flow -1,401.139-1,273.308-369.648-849.44-212.306-933.024-1,203.326-530.003-445.878-432.819-627.192-288.232-251.546-223.104-132.677-61.414-11.805-11.605
Financing Activities:
Debt Repayment -134.895112.733-335.61854.28286.296205.681-150000000-44.210.2519.87-0.24
Common Stock Issued 0300.5392.351284.94463.1330000000000000
Common Stock Repurchased 0-274.305-327.859-284.944-63.1330000000000000
Dividends Paid -545.68-437.564-1.6-515.928-836.813-843.452-1,161.021-206.395-458.845-392.256-305.088-163.44-136.2-113.5-2.774-2.328-30.718-0.565
Other Financing Activities -24.961-76.672,213.405-20.268-63.13340.5442.6626.350.335-0.035004.492-3.5971,148.0742.044-10.922-0.148
Financing Cash Flow -705.535-401.51,548.328-766.858-829.591-597.232-1,133.36-200.045-458.51-392.291-305.088-163.44-131.708-117.0971,101.0999.966-21.77-0.953
Other Information:
Effect Of Forex Changes On Cash 4.06732.961-6.775-4.8382.0835.781-5.8893.582.7020.011-0.775-0.248-0.737-0.577-000-0
Net Change In Cash -1,232.815-671.0422,356.884-246.808466.831-183.811-884.852708.344154.343157.15-264.53369.294-111.673-154.1291,102.70426.44519.178-0.554
Cash At End Of Period 1,318.1612,550.9763,222.018865.1351,111.942645.111828.9221,713.7741,005.43851.087693.937958.47889.1761,000.851,154.97952.27425.8296.651